| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.19 | 0.0001 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.002 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.004 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.004 |